<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35420441</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>SLC35B2 Acts in a Dual Role in the Host Sulfation Required for EV71 Infection.</ArticleTitle><Pagination><StartPage>e0204221</StartPage><MedlinePgn>e0204221</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e02042-21</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.02042-21</ELocationID><Abstract><AbstractText>As an important neurotropic enterovirus, enterovirus 71 (EV71) is occasionally associated with severe neurological diseases and high mortality rates in infants and young children. Understanding the interaction between host factors and EV71 will play a vital role in developing antivirals and optimizing vaccines. Here, we performed a genome-wide CRISPR-Cas9 knockout screen and revealed that scavenger receptor class B member 2 (SCARB2), solute carrier family 35 member B2 (SLC35B2), and beta-1,3-glucuronyltransferase 3 (B3GAT3) are essential in facilitating EV71 replication. Subsequently, the exploration of molecular mechanisms suggested that the knockout of SLC35B2 or B3GAT3, not SCARB2, led to a remarkable decrease in the binding of EV71 to cells and internalization into cells. Furthermore, we found that the infection efficiency for EV71 was positively correlated with the level of host cell sulfation, not simply with the amount of heparan sulfate, suggesting that an unidentified sulfated protein(s) must contribute to EV71 infection. In support of this idea, we screened possible sulfated proteins among the proteinous receptors for EV71 and confirmed that SCARB2 could uniquely interact with both tyrosyl protein sulfotransferases in humans. We then performed mass spectrometric analysis of SCARB2, identifying five sites with tyrosine sulfation. The function verification test indicated that there were more than five tyrosine-sulfated sites on SCARB2. Finally, we constructed a model for EV71 entry in which both heparan sulfate and SCARB2 are regulated by SLC35B2 and act cooperatively to support viral binding, internalization, and uncoating. Taken together, this is the first time that we performed the pooled CRISPR-Cas9 genetic screening to investigate the interplay of host cells and EV71. Furthermore, we found that a novel host factor, SLC35B2, played a dual role in regulating the overall sulfation comprising heparan sulfate sulfation and protein tyrosine sulfation, which are critical for EV71 entry. <b>IMPORTANCE</b> As the most important nonpolio neurotropic enterovirus lacking specific treatments, EV71 can transmit to the central nervous system, leading to severe and fatal neurological complications in infants and young children. The identification of new factors that facilitate or inhibit EV71 replication is crucial to uncover the mechanisms of viral infection and pathogenesis. To date, only a few host factors involved in EV71 infection have been characterized. Herein, we conducted a genome-wide CRISPR-Cas9 functional knockout (GeCKO) screen for the first time to study EV71 in HeLa cells. The screening results are presented as a ranked list of candidates, including 518 hits in the positive selection that facilitate EV71 replication and 1,044 hits in the negative selection that may be essential for cell growth and survival or for suppressing EV71 infection. We subsequently concentrated on the top three hits in the positive selection: SCARB2, SLC35B2, and B3GAT3. The knockout of any of these three genes confers strong resistance against EV71 infection. We confirmed that EV71 infection is codependent on two receptors, heparan sulfate and SCARB2. We also identified a host entry factor, SLC35B2, indirectly facilitating EV71 infection through regulation of the host cell sulfation, and determined a novel posttranslational modification, protein tyrosine sulfation existing in SCARB2. This study revealed that EV71 infectivity exhibits a significant positive correlation with the level of cellular sulfation regulated by SLC35B2. Due to the sulfation pathway being required for many distinct viruses, including but not limited to EV71 and respiratory syncytial virus (RSV), which were tested in this study, SLC35B2 represents a target of broad-spectrum antiviral therapy.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Dong</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xinghai</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhifei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-2102-9377</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Guodong</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Wuhan Canvest Biotechnology Co., Ltd., Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Wuhan Canvest Biotechnology Co., Ltd., Wuhan, Hubei, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qin</LastName><ForeName>Yali</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mingzhou</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5308-6897</Identifier><AffiliationInfo><Affiliation>State Key Laboratory of Virology and Modern Virology Research Center, College of Life Sciences, Wuhan Universitygrid.49470.3e, Wuhan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C476248">SLC35B2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000076988">Sulfate Transporters</NameOfSubstance></Chemical><Chemical><RegistryNumber>42HK56048U</RegistryNumber><NameOfSubstance UI="D014443">Tyrosine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9050-30-0</RegistryNumber><NameOfSubstance UI="D006497">Heparitin Sulfate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.1.135</RegistryNumber><NameOfSubstance UI="C000594393">B3GAT3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.4.1.17</RegistryNumber><NameOfSubstance UI="D014453">Glucuronosyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.8.2.-</RegistryNumber><NameOfSubstance UI="D015238">Sulfotransferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.8.2.20</RegistryNumber><NameOfSubstance UI="C039079">protein-tyrosine sulfotransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014453" MajorTopicYN="N">Glucuronosyltransferase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006497" MajorTopicYN="N">Heparitin Sulfate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000076988" MajorTopicYN="Y">Sulfate Transporters</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015238" MajorTopicYN="N">Sulfotransferases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014443" MajorTopicYN="N">Tyrosine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CRISPR screening</Keyword><Keyword MajorTopicYN="N">enterovirus 71</Keyword><Keyword MajorTopicYN="N">host entry factor</Keyword><Keyword MajorTopicYN="N">tyrosine sulfation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>12</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35420441</ArticleId><ArticleId IdType="pmc">PMC9093107</ArticleId><ArticleId IdType="doi">10.1128/jvi.02042-21</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26:91&#x2013;107. 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, Chen YJ, Yang YJ, Lin SJ, Yeh TF. 1999. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis 29:184&#x2013;190. 10.1086/520149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/520149</ArticleId><ArticleId IdType="pubmed">10433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryu WS, Kang B, Hong J, Hwang S, Kim A, Kim J, Cheon DS. 2010. Enterovirus 71 infection with central nervous system involvement, South Korea. Emerg Infect Dis 16:1764&#x2013;1766. 10.3201/eid1611.100104.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1611.100104</ArticleId><ArticleId IdType="pmc">PMC3294506</ArticleId><ArticleId IdType="pubmed">21029539</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med 15:798&#x2013;801. 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med 15:794&#x2013;797. 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Wang YF, Huang SW, Lo YC, Wang YH, Wu SR, Shieh DB, Chen SH, Wang JR, Lai MD, Chang CF. 2015. Cell surface nucleolin facilitates enterovirus 71 binding and infection. J Virol 89:4527&#x2013;4538. 10.1128/JVI.03498-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. 2011. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol 85:11809&#x2013;11820. 10.1128/JVI.00297-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N, Cong H, Tian H, Zhang H, Zhang W, Song L, Tien P. 2014. Cell surface vimentin is an attachment receptor for enterovirus 71. J Virol 88:5816&#x2013;5833. 10.1128/JVI.03826-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 87:611&#x2013;620. 10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. 2009. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J 6:141. 10.1186/1743-422X-6-141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren XX, Ma L, Liu QW, Li C, Huang Z, Wu L, Xiong SD, Wang JH, Wang HB. 2014. The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection. Virol J 11:47. 10.1186/1743-422X-11-47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-47</ArticleId><ArticleId IdType="pmc">PMC3995660</ArticleId><ArticleId IdType="pubmed">24620896</ArticleId></ArticleIdList></Reference><Reference><Citation>Too IHK, Bonne I, Tan EL, Chu JJH, Alonso S. 2018. Prohibitin plays a critical role in enterovirus 71 neuropathogenesis. PLoS Pathog 14:e1006778. 10.1371/journal.ppat.1006778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006778</ArticleId><ArticleId IdType="pmc">PMC5764453</ArticleId><ArticleId IdType="pubmed">29324904</ArticleId></ArticleIdList></Reference><Reference><Citation>He QQ, Ren S, Xia ZC, Cheng ZK, Peng NF, Zhu Y. 2018. Fibronectin facilitates enterovirus 71 infection by mediating viral entry. J Virol 92:e02251-17. 10.1128/JVI.02251-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02251-17</ArticleId><ArticleId IdType="pmc">PMC5899198</ArticleId><ArticleId IdType="pubmed">29467312</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, Shimanuki M, Shitara H, Taya C, Koike S. 2013. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci USA 110:14753&#x2013;14758. 10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewandrowski U, Moebius J, Walter U, Sickmann A. 2006. Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. Mol Cell Proteomics 5:226&#x2013;233. 10.1074/mcp.M500324-MCP200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M500324-MCP200</ArticleId><ArticleId IdType="pubmed">16263699</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Liu YT, Chang HY, Huang SW, Wang YF, Yu CK, Wang JR, Chang CF. 2012. Cell surface sialylation affects binding of enterovirus 71 to rhabdomyosarcoma and neuroblastoma cells. BMC Microbiol 12:162. 10.1186/1471-2180-12-162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2180-12-162</ArticleId><ArticleId IdType="pmc">PMC3478995</ArticleId><ArticleId IdType="pubmed">22853823</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain KM, Leong KL, Ng MM, Chu JJ. 2011. The essential role of clathrin-mediated endocytosis in the infectious entry of human enterovirus 71. J Biol Chem 286:309&#x2013;321. 10.1074/jbc.M110.168468.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.168468</ArticleId><ArticleId IdType="pmc">PMC3012988</ArticleId><ArticleId IdType="pubmed">20956521</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers WS, Tang J, Shaw GD, Camphausen RT. 2000. Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1. Cell 103:467&#x2013;479. 10.1016/s0092-8674(00)00138-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)00138-0</ArticleId><ArticleId IdType="pubmed">11081633</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Wakita T, Shimizu H. 2010. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog 6:e1001174. 10.1371/journal.ppat.1001174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001174</ArticleId><ArticleId IdType="pmc">PMC2973824</ArticleId><ArticleId IdType="pubmed">21079683</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamura K, Nishimura Y, Abo M, Wakita T, Shimizu H. 2011. Adaptive mutations in the genomes of enterovirus 71 strains following infection of mouse cells expressing human P-selectin glycoprotein ligand-1. J Gen Virol 92:287&#x2013;291. 10.1099/vir.0.022418-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.022418-0</ArticleId><ArticleId IdType="pmc">PMC3081077</ArticleId><ArticleId IdType="pubmed">20943886</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Lee H, Hafenstein S, Kataoka C, Wakita T, Bergelson JM, Shimizu H. 2013. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog 9:e1003511. 10.1371/journal.ppat.1003511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Busse-Wicher M, Wicher KB, Kusche-Gullberg M. 2014. The exostosin family: proteins with many functions. Matrix Biol 35:25&#x2013;33. 10.1016/j.matbio.2013.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2013.10.001</ArticleId><ArticleId IdType="pubmed">24128412</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabenstein DL. 2002. Heparin and heparan sulfate: structure and function. Nat Prod Rep 19:312&#x2013;331. 10.1039/b100916h.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b100916h</ArticleId><ArticleId IdType="pubmed">12137280</ArticleId></ArticleIdList></Reference><Reference><Citation>Shriver Z, Capila I, Venkataraman G, Sasisekharan R. 2012. Heparin and heparan sulfate: analyzing structure and microheterogeneity. Handb Exp Pharmacol 2012:159&#x2013;176. 10.1007/978-3-642-23056-1_8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-642-23056-1_8</ArticleId><ArticleId IdType="pmc">PMC3755452</ArticleId><ArticleId IdType="pubmed">22566225</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagno V, Tseligka ED, Jones ST, Tapparel C. 2019. Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias? Viruses 11:596. 10.3390/v11070596.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11070596</ArticleId><ArticleId IdType="pmc">PMC6669472</ArticleId><ArticleId IdType="pubmed">31266258</ArticleId></ArticleIdList></Reference><Reference><Citation>Artpradit C, Robinson LN, Gavrilov BK, Rurak TT, Ruchirawat M, Sasisekharan R. 2013. Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles. Virus Res 176:69&#x2013;77. 10.1016/j.virusres.2013.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2013.04.017</ArticleId><ArticleId IdType="pmc">PMC4145673</ArticleId><ArticleId IdType="pubmed">23707399</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13&#x2013;22. 10.1016/s0092-8674(00)80058-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)80058-6</ArticleId><ArticleId IdType="pubmed">10520990</ArticleId></ArticleIdList></Reference><Reference><Citation>Giroglou T, Florin L, Sch&#xe4;fer F, Streeck RE, Sapp M. 2001. Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75:1565&#x2013;1570. 10.1128/JVI.75.3.1565-1570.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.3.1565-1570.2001</ArticleId><ArticleId IdType="pmc">PMC114064</ArticleId><ArticleId IdType="pubmed">11152531</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol 71:5115&#x2013;5123. 10.1128/JVI.71.7.5115-5123.1997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.71.7.5115-5123.1997</ArticleId><ArticleId IdType="pmc">PMC191746</ArticleId><ArticleId IdType="pubmed">9188578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Pfeiffer JK. 2016. Emergence of a large-plaque variant in mice infected with coxsackievirus B3. mBio 7:e00119-16. 10.1128/mBio.00119-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00119-16</ArticleId><ArticleId IdType="pmc">PMC4817249</ArticleId><ArticleId IdType="pubmed">27025249</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochkov YA, Watters K, Basnet S, Sijapati S, Hill M, Palmenberg AC, Gern JE. 2016. Mutations in VP1 and 3A proteins improve binding and replication of rhinovirus C15 in HeLa-E8 cells. Virology 499:350&#x2013;360. 10.1016/j.virol.2016.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.09.025</ArticleId><ArticleId IdType="pmc">PMC5110265</ArticleId><ArticleId IdType="pubmed">27743961</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AG, Pickl-Herk A, Gajdzik L, Marlovits TC, Fuchs R, Blaas D. 2011. Entry of a heparan sulphate-binding HRV8 variant strictly depends on dynamin but not on clathrin, caveolin, and flotillin. Virology 412:55&#x2013;67. 10.1016/j.virol.2010.12.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2010.12.042</ArticleId><ArticleId IdType="pubmed">21262518</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka ED, Sobo K, Stoppini L, Cagno V, Abdul F, Piuz I, Meylan P, Huang S, Constant S, Tapparel C. 2018. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog 14:e1007190. 10.1371/journal.ppat.1007190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, Petty TJ, Schibler M, Martinez Y, Gerlach D, van Belle S, Turin L, Zdobnov E, Kaiser L, Tapparel C. 2012. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog 8:e1002826. 10.1371/journal.ppat.1002826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002826</ArticleId><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson SM, McNally BA, Ioannidis I, Flano E, Teng MN, Oomens AG, Walsh EE, Peeples ME. 2015. Respiratory syncytial virus uses CX3CR1 as a receptor on primary human airway epithelial cultures. PLoS Pathog 11:e1005318. 10.1371/journal.ppat.1005318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005318</ArticleId><ArticleId IdType="pmc">PMC4676609</ArticleId><ArticleId IdType="pubmed">26658574</ArticleId></ArticleIdList></Reference><Reference><Citation>Cagno V, Donalisio M, Civra A, Volante M, Veccelli E, Oreste P, Rusnati M, Lembo D. 2014. Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures. Antimicrob Agents Chemother 58:4782&#x2013;4794. 10.1128/AAC.02594-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.02594-14</ArticleId><ArticleId IdType="pmc">PMC4135974</ArticleId><ArticleId IdType="pubmed">24914125</ArticleId></ArticleIdList></Reference><Reference><Citation>Donalisio M, Rusnati M, Cagno V, Civra A, Bugatti A, Giuliani A, Pirri G, Volante M, Papotti M, Landolfo S, Lembo D. 2012. Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. Antimicrob Agents Chemother 56:5278&#x2013;5288. 10.1128/AAC.00771-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.00771-12</ArticleId><ArticleId IdType="pmc">PMC3457392</ArticleId><ArticleId IdType="pubmed">22850525</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose S, Banerjee AK. 2002. Role of heparan sulfate in human parainfluenza virus type 3 infection. Virology 298:73&#x2013;83. 10.1006/viro.2002.1484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2002.1484</ArticleId><ArticleId IdType="pubmed">12093175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, Collins PL, Pickles RJ. 2005. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J Virol 79:1113&#x2013;1124. 10.1128/JVI.79.2.1113-1124.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.2.1113-1124.2005</ArticleId><ArticleId IdType="pmc">PMC538579</ArticleId><ArticleId IdType="pubmed">15613339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SY, Zhao J, Liu X, Fraser K, Lin L, Zhang X, Zhang F, Dordick JS, Linhardt RJ. 2017. Interaction of Zika virus envelope protein with glycosaminoglycans. Biochemistry 56:1151&#x2013;1162. 10.1021/acs.biochem.6b01056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.biochem.6b01056</ArticleId><ArticleId IdType="pmc">PMC7579681</ArticleId><ArticleId IdType="pubmed">28151637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghezzi S, Cooper L, Rubio A, Pagani I, Capobianchi MR, Ippolito G, Pelletier J, Meneghetti MCZ, Lima MA, Skidmore MA, Broccoli V, Yates EA, Vicenzi E. 2017. Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells. Antiviral Res 140:13&#x2013;17. 10.1016/j.antiviral.2016.12.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.12.023</ArticleId><ArticleId IdType="pmc">PMC7113768</ArticleId><ArticleId IdType="pubmed">28063994</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao H, Lin Y, He J, Zhou S, Liang M, Huang C, Li X, Liu C, Zhang P. 2019. Role of heparan sulfate in the Zika virus entry, replication, and cell death. Virology 529:91&#x2013;100. 10.1016/j.virol.2019.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2019.01.019</ArticleId><ArticleId IdType="pubmed">30684694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Koike S. 2020. Cellular receptors for enterovirus A71. J Biomed Sci 27:23. 10.1186/s12929-020-0615-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-020-0615-9</ArticleId><ArticleId IdType="pmc">PMC6954530</ArticleId><ArticleId IdType="pubmed">31924205</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeuerle PA, Huttner WB. 1987. Tyrosine sulfation is a trans-Golgi-specific protein modification. J Cell Biol 105:2655&#x2013;2664. 10.1083/jcb.105.6.2655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.105.6.2655</ArticleId><ArticleId IdType="pmc">PMC2114704</ArticleId><ArticleId IdType="pubmed">3121635</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos JP, Lopes-Cardozo M, Gadella BM. 1994. Metabolic and functional aspects of sulfogalactolipids. Biochim Biophys Acta 1211:125&#x2013;149. 10.1016/0005-2760(94)90262-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0005-2760(94)90262-3</ArticleId><ArticleId IdType="pubmed">8117740</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin Y, Wang A, Feng L, Wang Y, Zhang H, Zhang I, Bany BM, Ma L. 2018. Heparan sulfate proteoglycan sulfation regulates uterine differentiation and signaling during embryo implantation. Endocrinology 159:2459&#x2013;2472. 10.1210/en.2018-00105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2018-00105</ArticleId><ArticleId IdType="pmc">PMC6692868</ArticleId><ArticleId IdType="pubmed">29688404</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatachalam KV. 2003. Human 3&#x2032;-phosphoadenosine 5&#x2032;-phosphosulfate (PAPS) synthase: biochemistry, molecular biology and genetic deficiency. IUBMB Life 55:1&#x2013;11. 10.1080/1521654031000072148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1521654031000072148</ArticleId><ArticleId IdType="pubmed">12716056</ArticleId></ArticleIdList></Reference><Reference><Citation>Besset S, Vincourt JB, Amalric F, Girard JP. 2000. Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells. FASEB J 14:345&#x2013;354. 10.1096/fasebj.14.2.345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.14.2.345</ArticleId><ArticleId IdType="pubmed">10657990</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamiyama S, Suda T, Ueda R, Suzuki M, Okubo R, Kikuchi N, Chiba Y, Goto S, Toyoda H, Saigo K, Watanabe M, Narimatsu H, Jigami Y, Nishihara S. 2003. Molecular cloning and identification of 3&#x2032;-phosphoadenosine 5&#x2032;-phosphosulfate transporter. J Biol Chem 278:25958&#x2013;25963. 10.1074/jbc.M302439200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M302439200</ArticleId><ArticleId IdType="pubmed">12716889</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman KG, Bertozzi CR. 1999. Carbohydrate sulfotransferases: mediators of extracellular communication. Chem Biol 6:R9&#x2013;R22. 10.1016/S1074-5521(99)80014-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-5521(99)80014-3</ArticleId><ArticleId IdType="pubmed">9889154</ArticleId></ArticleIdList></Reference><Reference><Citation>Westmuckett AD, Thacker KM, Moore KL. 2011. Tyrosine sulfation of native mouse Psgl-1 is required for optimal leukocyte rolling on P-selectin in vivo. PLoS One 6:e20406. 10.1371/journal.pone.0020406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0020406</ArticleId><ArticleId IdType="pmc">PMC3102115</ArticleId><ArticleId IdType="pubmed">21633705</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzan M, Mirzabekov T, Kolchinsky P, Wyatt R, Cayabyab M, Gerard NP, Gerard C, Sodroski J, Choe H. 1999. Tyrosine sulfation of the amino terminus of CCR5 facilitates HIV-1 entry. Cell 96:667&#x2013;676. 10.1016/s0092-8674(00)80577-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)80577-2</ArticleId><ArticleId IdType="pubmed">10089882</ArticleId></ArticleIdList></Reference><Reference><Citation>Leyte A, van Schijndel HB, Niehrs C, Huttner WB, Verbeet MP, Mertens K, van Mourik JA. 1991. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 266:740&#x2013;746. 10.1016/S0021-9258(17)35234-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)35234-1</ArticleId><ArticleId IdType="pubmed">1898735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu KX, Phuektes P, Kumar P, Goh GY, Moreau D, Chow VT, Bard F, Chu JJ. 2016. Human genome-wide RNAi screen reveals host factors required for enterovirus 71 replication. Nat Commun 7:13150. 10.1038/ncomms13150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13150</ArticleId><ArticleId IdType="pmc">PMC5071646</ArticleId><ArticleId IdType="pubmed">27748395</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeung ML, Jia L, Yip CCY, Chan JFW, Teng JLL, Chan KH, Cai JP, Zhang C, Zhang AJ, Wong WM, Kok KH, Lau SKP, Woo PCY, Lo JYC, Jin DY, Shih SR, Yuen KY. 2018. Human tryptophanyl-tRNA synthetase is an IFN-&#x3b3;-inducible entry factor for Enterovirus. J Clin Invest 128:5163&#x2013;5177. 10.1172/JCI99411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99411</ArticleId><ArticleId IdType="pmc">PMC6205371</ArticleId><ArticleId IdType="pubmed">30153112</ArticleId></ArticleIdList></Reference><Reference><Citation>Housden BE, Perrimon N. 2016. Comparing CRISPR and RNAi-based screening technologies. Nat Biotechnol 34:621&#x2013;623. 10.1038/nbt.3599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3599</ArticleId><ArticleId IdType="pubmed">27281421</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgens DW, Deans RM, Li A, Bassik MC. 2016. Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes. Nat Biotechnol 34:634&#x2013;636. 10.1038/nbt.3567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3567</ArticleId><ArticleId IdType="pmc">PMC4900911</ArticleId><ArticleId IdType="pubmed">27159373</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Miner JJ, Gorman MJ, Rausch K, Ramage H, White JP, Zuiani A, Zhang P, Fernandez E, Zhang Q, Dowd KA, Pierson TC, Cherry S, Diamond MS. 2016. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature 535:164&#x2013;168. 10.1038/nature18625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature18625</ArticleId><ArticleId IdType="pmc">PMC4945490</ArticleId><ArticleId IdType="pubmed">27383988</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson RB, Ohlson MB, Eitson JL, Kumar A, McDougal MB, Boys IN, Mar KB, De La Cruz-Rivera PC, Douglas C, Konopka G, Xing C, Schoggins JW. 2018. A CRISPR screen identifies IFI6 as an ER-resident interferon effector that blocks flavivirus replication. Nat Microbiol 3:1214&#x2013;1223. 10.1038/s41564-018-0244-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0244-1</ArticleId><ArticleId IdType="pmc">PMC6202210</ArticleId><ArticleId IdType="pubmed">30224801</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Muffat J, Omer Javed A, Keys HR, Lungjangwa T, Bosch I, Khan M, Virgilio MC, Gehrke L, Sabatini DM, Jaenisch R. 2019. Genome-wide CRISPR screen for Zika virus resistance in human neural cells. Proc Natl Acad Sci USA 116:9527&#x2013;9532. 10.1073/pnas.1900867116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1900867116</ArticleId><ArticleId IdType="pmc">PMC6510995</ArticleId><ArticleId IdType="pubmed">31019072</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann HH, Schneider WM, Rozen-Gagnon K, Miles LA, Schuster F, Razooky B, Jacobson E, Wu X, Yi S, Rudin CM, MacDonald MR, McMullan LK, Poirier JT, Rice CM. 2021. TMEM41B is a pan-flavivirus host factor. Cell 184:133&#x2013;148.e20. 10.1016/j.cell.2020.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.005</ArticleId><ArticleId IdType="pmc">PMC7954666</ArticleId><ArticleId IdType="pubmed">33338421</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F. 2014. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343:84&#x2013;87. 10.1126/science.1247005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1247005</ArticleId><ArticleId IdType="pmc">PMC4089965</ArticleId><ArticleId IdType="pubmed">24336571</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Perez JT, Chen C, Li Y, Benitez A, Kandasamy M, Lee Y, Andrade J, tenOever B, Manicassamy B. 2018. Genome-wide CRISPR/Cas9 screen identifies host factors essential for influenza virus replication. Cell Rep 23:596&#x2013;607. 10.1016/j.celrep.2018.03.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.03.045</ArticleId><ArticleId IdType="pmc">PMC5939577</ArticleId><ArticleId IdType="pubmed">29642015</ArticleId></ArticleIdList></Reference><Reference><Citation>Joung J, Konermann S, Gootenberg JS, Abudayyeh OO, Platt RJ, Brigham MD, Sanjana NE, Zhang F. 2017. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat Protoc 12:828&#x2013;863. 10.1038/nprot.2017.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2017.016</ArticleId><ArticleId IdType="pmc">PMC5526071</ArticleId><ArticleId IdType="pubmed">28333914</ArticleId></ArticleIdList></Reference><Reference><Citation>Park RJ, Wang T, Koundakjian D, Hultquist JF, Lamothe-Molina P, Monel B, Schumann K, Yu H, Krupzcak KM, Garcia-Beltran W, Piechocka-Trocha A, Krogan NJ, Marson A, Sabatini DM, Lander ES, Hacohen N, Walker BD. 2017. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nat Genet 49:193&#x2013;203. 10.1038/ng.3741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3741</ArticleId><ArticleId IdType="pmc">PMC5511375</ArticleId><ArticleId IdType="pubmed">27992415</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondel CJ, Park JS, Hubbard TP, Pacheco AR, Kuehl CJ, Walsh MJ, Davis BM, Gewurz BE, Doench JG, Waldor MK. 2016. CRISPR/Cas9 screens reveal requirements for host cell sulfation and fucosylation in bacterial type III secretion system-mediated cytotoxicity. Cell Host Microbe 20:226&#x2013;237. 10.1016/j.chom.2016.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2016.06.010</ArticleId><ArticleId IdType="pmc">PMC4982808</ArticleId><ArticleId IdType="pubmed">27453484</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosmarin DM, Carette JE, Olive AJ, Starnbach MN, Brummelkamp TR, Ploegh HL. 2012. Attachment of Chlamydia trachomatis L2 to host cells requires sulfation. Proc Natl Acad Sci USA 109:10059&#x2013;10064. 10.1073/pnas.1120244109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1120244109</ArticleId><ArticleId IdType="pmc">PMC3382535</ArticleId><ArticleId IdType="pubmed">22675117</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry GE, Tse LV. 2017. Virus binding and internalization assay for adeno-associated virus. Bio Protoc 7:e2110. 10.21769/BioProtoc.2110.</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.2110</ArticleId><ArticleId IdType="pmc">PMC5718205</ArticleId><ArticleId IdType="pubmed">29226179</ArticleId></ArticleIdList></Reference><Reference><Citation>Reczek D, Schwake M, Schr&#xf6;der J, Hughes H, Blanz J, Jin X, Brondyk W, Van Patten S, Edmunds T, Saftig P. 2007. LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase. Cell 131:770&#x2013;783. 10.1016/j.cell.2007.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.018</ArticleId><ArticleId IdType="pubmed">18022370</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Koike S. 2011. Identification of a human SCARB2 region that is important for enterovirus 71 binding and infection. J Virol 85:4937&#x2013;4946. 10.1128/JVI.02358-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02358-10</ArticleId><ArticleId IdType="pmc">PMC3126200</ArticleId><ArticleId IdType="pubmed">21389126</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin YW, Lin HY, Tsou YL, Chitra E, Hsiao KN, Shao HY, Liu CC, Sia C, Chong P, Chow YH. 2012. Human SCARB2-mediated entry and endocytosis of EV71. PLoS One 7:e30507. 10.1371/journal.pone.0030507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0030507</ArticleId><ArticleId IdType="pmc">PMC3260287</ArticleId><ArticleId IdType="pubmed">22272359</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang M, Wang X, Wang Q, Wang Y, Lin J, Sun Y, Li X, Zhang L, Lou Z, Wang J, Rao Z. 2014. Molecular mechanism of SCARB2-mediated attachment and uncoating of EV71. Protein Cell 5:692&#x2013;703. 10.1007/s13238-014-0087-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-014-0087-3</ArticleId><ArticleId IdType="pmc">PMC4145081</ArticleId><ArticleId IdType="pubmed">24986489</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. 2013. Functional comparison of SCARB2 and PSGL1 as receptors for enterovirus 71. J Virol 87:3335&#x2013;3347. 10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwake M, Schr&#xf6;der B, Saftig P. 2013. Lysosomal membrane proteins and their central role in physiology. Traffic 14:739&#x2013;748. 10.1111/tra.12056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tra.12056</ArticleId><ArticleId IdType="pubmed">23387372</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallak LK, Spillmann D, Collins PL, Peeples ME. 2000. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J Virol 74:10508&#x2013;10513. 10.1128/jvi.74.22.10508-10513.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.22.10508-10513.2000</ArticleId><ArticleId IdType="pmc">PMC110925</ArticleId><ArticleId IdType="pubmed">11044095</ArticleId></ArticleIdList></Reference><Reference><Citation>Seibert C, Cadene M, Sanfiz A, Chait BT, Sakmar TP. 2002. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence. Proc Natl Acad Sci USA 99:11031&#x2013;11036. 10.1073/pnas.172380899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.172380899</ArticleId><ArticleId IdType="pmc">PMC123205</ArticleId><ArticleId IdType="pubmed">12169668</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu MC, Yu S, Sy J, Redman CM, Lipmann F. 1985. Tyrosine sulfation of proteins from the human hepatoma cell line HepG2. Proc Natl Acad Sci USA 82:7160&#x2013;7164. 10.1073/pnas.82.21.7160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.82.21.7160</ArticleId><ArticleId IdType="pmc">PMC390808</ArticleId><ArticleId IdType="pubmed">2414772</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Sam IC, Lee VS, Wong HV, Chan YF. 2017. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology 501:79&#x2013;87. 10.1016/j.virol.2016.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CK, Wu SR, Chen YC, Lee KJ, Chung NH, Lu YJ, Yu SL, Liu CC, Chow YH. 2018. Mutations in VP1 and 5&#x2032;-UTR affect enterovirus 71 virulence. Sci Rep 8:6688. 10.1038/s41598-018-25091-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-25091-7</ArticleId><ArticleId IdType="pmc">PMC5923339</ArticleId><ArticleId IdType="pubmed">29703921</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Sudaka Y, Takashino A, Imura A, Fujii K, Koike S. 2018. Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice. J Virol 92:e00681-18. 10.1128/JVI.00681-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00681-18</ArticleId><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Sudaka Y, Takashino A, Kobayashi K, Kataoka C, Suzuki T, Iwata-Yoshikawa N, Kotani O, Ami Y, Shimizu H, Nagata N, Mizuta K, Matsuzaki Y, Koike S. 2018. VP1 amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection. J Virol 92:e00682-18. 10.1128/JVI.00682-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00682-18</ArticleId><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Tee HK, Tan CW, Yogarajah T, Lee MHP, Chai HJ, Hanapi NA, Yusof SR, Ong KC, Lee VS, Sam IC, Chan YF. 2019. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice. PLoS Pathog 15:e1007863. 10.1371/journal.ppat.1007863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007863</ArticleId><ArticleId IdType="pmc">PMC6881073</ArticleId><ArticleId IdType="pubmed">31730673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Mizuta K, Koike S. 2020. Heparan sulfate attachment receptor is a major selection factor for attenuated enterovirus 71 mutants during cell culture adaptation. PLoS Pathog 16:e1008428. 10.1371/journal.ppat.1008428.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008428</ArticleId><ArticleId IdType="pmc">PMC7105141</ArticleId><ArticleId IdType="pubmed">32187235</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen TM, Sandoval DR, Spliid CB, Pihl J, Perrett HR, Painter CD, Narayanan A, Majowicz SA, Kwong EM, McVicar RN, Thacker BE, Glass CA, Yang Z, Torres JL, Golden GJ, Bartels PL, Porell RN, Garretson AF, Laubach L, Feldman J, Yin X, Pu Y, Hauser BM, Caradonna TM, Kellman BP, Martino C, Gordts P, Chanda SK, Schmidt AG, Godula K, Leibel SL, Jose J, Corbett KD, Ward AB, Carlin AF, Esko JD. 2020. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell 183:1043&#x2013;1057.e15. 10.1016/j.cell.2020.09.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.033</ArticleId><ArticleId IdType="pmc">PMC7489987</ArticleId><ArticleId IdType="pubmed">32970989</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider WM, Luna JM, Hoffmann HH, S&#xe1;nchez-Rivera FJ, Leal AA, Ashbrook AW, Le Pen J, Ricardo-Lax I, Michailidis E, Peace A, Stenzel AF, Lowe SW, MacDonald MR, Rice CM, Poirier JT. 2021. Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks. Cell 184:120&#x2013;132.e14. 10.1016/j.cell.2020.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.006</ArticleId><ArticleId IdType="pmc">PMC7796900</ArticleId><ArticleId IdType="pubmed">33382968</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Simoneau CR, Kulsuptrakul J, Bouhaddou M, Travisano KA, Hayashi JM, Carlson-Stevermer J, Zengel JR, Richards CM, Fozouni P, Oki J, Rodriguez L, Joehnk B, Walcott K, Holden K, Sil A, Carette JE, Krogan NJ, Ott M, Puschnik AS. 2021. Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses. Cell 184:106&#x2013;119.e14. 10.1016/j.cell.2020.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.004</ArticleId><ArticleId IdType="pmc">PMC7723770</ArticleId><ArticleId IdType="pubmed">33333024</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis G, Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 4:P3. 10.1186/gb-2003-4-5-p3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2003-4-5-p3</ArticleId><ArticleId IdType="pubmed">12734009</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>